These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2542193

  • 1. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, Shapiro WR, Mealey J, Ransohoff J, Paoletti P.
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1389-96. PubMed ID: 2542193
    [Abstract] [Full Text] [Related]

  • 2. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
    Nelson DF, Diener-West M, Weinstein AS, Schoenfeld D, Nelson JS, Sause WT, Chang CH, Goodman R, Carabell S.
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
    [Abstract] [Full Text] [Related]

  • 3. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF, Curran WJ, Scott C, Nelson JS, Weinstein AS, Ahmad K, Constine LS, Murray K, Powlis WD, Mohiuddin M.
    Int J Radiat Oncol Biol Phys; 1993 Jan 15; 25(2):193-207. PubMed ID: 8380567
    [Abstract] [Full Text] [Related]

  • 4. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
    Nelson DF, Schoenfeld D, Weinstein AS, Nelson JS, Wasserman T, Goodman RL, Carabell S.
    Int J Radiat Oncol Biol Phys; 1983 Aug 15; 9(8):1143-51. PubMed ID: 6347995
    [Abstract] [Full Text] [Related]

  • 5. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M, Scott CB, Nelson DF, Gaspar LE, Murray KJ, Fischbach JA, Nelson JS, Weinstein AS, Curran WJ.
    Cancer; 1996 Apr 15; 77(8):1535-43. PubMed ID: 8608540
    [Abstract] [Full Text] [Related]

  • 6. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.
    Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ.
    Int J Radiat Oncol Biol Phys; 2004 Nov 01; 60(3):853-60. PubMed ID: 15465203
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Misonidazole combined with hyperfractionation in the management of malignant glioma.
    Fulton DS, Urtasun RC, Shin KH, Geggie PH, Thomas H, Muller PJ, Moody J, Tanasichuk H, Mielke B, Johnson E.
    Int J Radiat Oncol Biol Phys; 1984 Sep 01; 10(9):1709-12. PubMed ID: 6090367
    [Abstract] [Full Text] [Related]

  • 9. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y.
    Cancer; 1983 Sep 15; 52(6):997-1007. PubMed ID: 6349785
    [Abstract] [Full Text] [Related]

  • 10. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC, Gaspar L, Imperato J, Salter M, Herndon J, Dowling S.
    Am J Clin Oncol; 1993 Aug 15; 16(4):277-83. PubMed ID: 8392285
    [Abstract] [Full Text] [Related]

  • 11. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X, Lemaire JJ, Tortochaux J, Van-Praagh I, Kwiatkowski F, Vincent C, Bailly C, Verrelle P, Irthum B, Chazal J, Bay JO.
    Bone Marrow Transplant; 2003 Apr 15; 31(7):559-64. PubMed ID: 12692621
    [Abstract] [Full Text] [Related]

  • 12. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma.
    Green SB, Byar DP, Walker MD, Pistenmaa DA, Alexander E, Batzdorf U, Brooks WH, Hunt WE, Mealey J, Odom GL, Paoletti P, Ransohoff J, Robertson JT, Selker RG, Shapiro WR, Smith KR, Wilson CB, Strike TA.
    Cancer Treat Rep; 1983 Feb 15; 67(2):121-32. PubMed ID: 6337710
    [Abstract] [Full Text] [Related]

  • 13. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ.
    J Neurooncol; 2018 Mar 15; 137(1):39-47. PubMed ID: 29404979
    [Abstract] [Full Text] [Related]

  • 14. A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma.
    Shapiro WR, Green SB, Burger PC, Selker RG, VanGilder JC, Robertson JT, Mealey J, Ransohff J, Mahaley MS.
    J Neurosurg; 1992 May 15; 76(5):772-81. PubMed ID: 1564540
    [Abstract] [Full Text] [Related]

  • 15. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D, Sipos L, Vitanovics D.
    Ideggyogy Sz; 2002 Jan 20; 55(1-2):38-44. PubMed ID: 12122942
    [Abstract] [Full Text] [Related]

  • 16. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
    Levin VA, Wilson CB, Davis R, Wara WM, Pischer TL, Irwin L.
    J Neurosurg; 1979 Oct 20; 51(4):526-32. PubMed ID: 225456
    [No Abstract] [Full Text] [Related]

  • 17. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.
    Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CB, Strike TA.
    N Engl J Med; 1980 Dec 04; 303(23):1323-9. PubMed ID: 7001230
    [Abstract] [Full Text] [Related]

  • 18. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S, Brain Tumor Cooperative Group.
    Neurosurgery; 2002 Aug 04; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [Abstract] [Full Text] [Related]

  • 19. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.
    Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y.
    Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028
    [Abstract] [Full Text] [Related]

  • 20. Treatment of supratentorial high grade gliomas with split course high fractional dose postoperative radiotherapy.
    Marcial-Vega VA, Wharam MD, Leibel S, Clark A, Zweig R, Order SE.
    Int J Radiat Oncol Biol Phys; 1989 Jun 01; 16(6):1419-24. PubMed ID: 2722586
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.